Many plans do not cover GLP-1s for weight loss at all (only 19% of large employers did in 2025, per KFF), and those that do usually require prior authorization documenting your BMI, related conditions, and prior attempts
NPY/AgRP, Neuropeptide Y/Agouti gene related peptide
Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regarding glycaemic control and body weight reduction
Chronic Dis
Fortunately, there are several natural ways to stop GERD palpitations and support your overall digestive and heart health
We do not sell research chemicals, we do not dispense without an evaluation, and we do not provide peptides to anyone who has not gone through intake